Bruker (BRKRP) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 66.99% |
| 10 | Bruker | - | - | 379.80 Mn | -65.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.56% |
| Dec 31, 2025 | 47.40% |
| Sep 30, 2025 | -143.47% |
| Jun 30, 2025 | -75.26% |
| Mar 31, 2025 | -81.27% |
| Dec 31, 2024 | -80.35% |
| Sep 30, 2024 | -81.61% |
| Jun 30, 2024 | -86.14% |
| Mar 31, 2024 | -55.64% |
| Dec 31, 2023 | -22.79% |
| Sep 30, 2023 | -10.04% |
| Jun 30, 2023 | 219.63% |
| Mar 31, 2023 | 24.12% |
| Dec 31, 2014 | -27.05% |
| Sep 30, 2014 | -84.44% |
| Jun 30, 2014 | -18.62% |
| Mar 31, 2014 | 74.48% |
| Dec 31, 2013 | 59.50% |
| Sep 30, 2013 | -44.50% |
| Jun 30, 2013 | 122.23% |
| Mar 31, 2013 | -62.25% |
| Dec 31, 2012 | -55.49% |
| Sep 30, 2012 | -19.60% |
| Jun 30, 2012 | -73.89% |
| Mar 31, 2012 | -39.16% |
| Dec 31, 2011 | -33.40% |
| Sep 30, 2011 | -32.64% |
| Jun 30, 2011 | -17.03% |